• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany.

作者信息

Seidel Maximilian, Hölzer Bodo, Appel Heiner, Babel Nina, Westhoff Timm H

机构信息

Medical Department I, University Hospital Marien Hospital Herne, Ruhr-University Bochum, Hölkeskampring 40, 44625, Herne, Germany.

Dialysezentrum Hamm, Hamm, Germany.

出版信息

J Nephrol. 2020 Oct;33(5):871-874. doi: 10.1007/s40620-020-00828-8.

DOI:10.1007/s40620-020-00828-8
PMID:32804355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7429939/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1236/7557482/d8e93c67990d/40620_2020_828_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1236/7557482/d8e93c67990d/40620_2020_828_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1236/7557482/d8e93c67990d/40620_2020_828_Fig1_HTML.jpg

相似文献

1
Impact of renal disease and comorbidities on mortality in hemodialysis patients with COVID-19: a multicenter experience from Germany.肾脏疾病及合并症对COVID-19血液透析患者死亡率的影响：来自德国的多中心经验
J Nephrol. 2020 Oct;33(5):871-874. doi: 10.1007/s40620-020-00828-8.
2
High mortality of CKD patients on hemodialysis with Covid-19 in Brazil.巴西接受血液透析的慢性肾脏病患者感染新冠病毒后的高死亡率。
J Nephrol. 2020 Oct;33(5):875-877. doi: 10.1007/s40620-020-00823-z.
3
Novel coronavirus(Covid19), Its renal manifestations, and complications.新型冠状病毒（新冠病毒19）、其肾脏表现及并发症。
Urol J. 2020 Sep 13;17(5):558-559. doi: 10.22037/uj.v16i7.6431.
4
COVID-19 and the kidney.新型冠状病毒肺炎与肾脏。
Cleve Clin J Med. 2020 Oct 1;87(10):619-631. doi: 10.3949/ccjm.87a.20072.
5
Kidney diseases in the time of COVID-19: major challenges to patient care.新冠疫情时期的肾脏疾病：患者护理面临的重大挑战
J Clin Invest. 2020 Jun 1;130(6):2749-2751. doi: 10.1172/JCI138871.
6
Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units.血液透析单位中严重急性呼吸综合征冠状病毒2（COVID-19）疫情的管理
Nefrologia (Engl Ed). 2020 May-Jun;40(3):258-264. doi: 10.1016/j.nefro.2020.04.001. Epub 2020 Apr 8.
7
The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?透析患者的新冠病毒感染：居家肾脏替代治疗是改善患者管理的一种方法吗？
J Nephrol. 2020 Aug;33(4):629-631. doi: 10.1007/s40620-020-00784-3.
8
Long-Term Hemodialysis during the COVID-19 Pandemic.新冠疫情期间的长期血液透析
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1073-1074. doi: 10.2215/CJN.09100620. Epub 2020 Jul 2.
9
Patients' and healthcare personnel expectations for SARS-CoV-2 screening in dialysis unit during the Covid-19 pandemic.新冠疫情期间患者及医护人员对透析单元中新型冠状病毒2型（SARS-CoV-2）筛查的期望
J Nephrol. 2020 Oct;33(5):879-881. doi: 10.1007/s40620-020-00811-3.
10
Prevention and management of COVID-19 in hemodialysis centers.COVID-19 在血液透析中心的预防和管理。
Am J Manag Care. 2020 Aug 1;26(8):e237-e238. doi: 10.37765/ajmc.2020.43887.

引用本文的文献

1
Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.肾移植受者和透析患者对 SARS-CoV-2 的体液免疫：SARS-CoV-2 感染和接种疫苗后解析的 IgA 和 IgG 模式。
Virol J. 2024 Jun 13;21(1):138. doi: 10.1186/s12985-024-02410-1.
2
Clinical Presentation and Outcomes of Hospitalized Patients with Chronic Kidney Disease and COVID-19 Variant Omicron.慢性肾脏病合并新冠病毒奥密克戎变异株住院患者的临床表现及预后
Ther Clin Risk Manag. 2024 May 18;20:275-288. doi: 10.2147/TCRM.S458859. eCollection 2024.
3
Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease.

本文引用的文献

1
Time Course of a Second Outbreak of COVID-19 in Beijing, China, June-July 2020.2020 年 6-7 月中国北京第二波 COVID-19 爆发的时间进程。
JAMA. 2020 Oct 13;324(14):1458-1459. doi: 10.1001/jama.2020.15894.
2
Neointimal hyperplasia in the inferior vena cava of adenine-induced chronic kidney disease rats with aortocaval fistulas.腺嘌呤诱导的慢性肾病伴腹主动脉-腔静脉瘘大鼠腔静脉内膜增生。
Clin Exp Nephrol. 2020 Nov;24(11):1007-1014. doi: 10.1007/s10157-020-01927-3. Epub 2020 Jul 14.
3
COVID-19 Outbreak in a Large Hemodialysis Center in Lombardy, Italy.
与终末期肾病患者 SARS-CoV-2 感染和预后相关的透析参数。
Ann Med. 2024 Dec;56(1):2343890. doi: 10.1080/07853890.2024.2343890. Epub 2024 May 13.
4
Infection status and clinical characteristics of COVID-19 in maintenance hemodialysis patients in Wuhan during the omicron pandemic.奥密克戎疫情期间武汉维持性血液透析患者 COVID-19 的感染状况和临床特征。
Medicine (Baltimore). 2023 Sep 8;102(36):e35063. doi: 10.1097/MD.0000000000035063.
5
Predictors of mortality in critically ill patients with COVID-19 and diabetes.COVID-19 合并糖尿病危重症患者的死亡预测因素。
Braz J Med Biol Res. 2023 Aug 14;56:e12728. doi: 10.1590/1414-431X2023e12728. eCollection 2023.
6
Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine.COVID-19 感染在透析患者中的临床表现和 COVID-19 疫苗的保护作用。
Inflamm Res. 2023 May;72(5):989-1000. doi: 10.1007/s00011-023-01723-1. Epub 2023 Apr 1.
7
Image-guided tunneled peritoneal dialysis catheter placement.影像引导下带隧道的腹膜透析导管置入术。
Cardiovasc Diagn Ther. 2023 Feb 28;13(1):311-322. doi: 10.21037/cdt-21-579. Epub 2022 Jan 10.
8
Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?入院时的全身免疫炎症指数能否预测 SARS-CoV-2 感染的慢性肾脏病患者的住院死亡率？
Nefrologia (Engl Ed). 2022 Sep-Oct;42(5):549-558. doi: 10.1016/j.nefroe.2021.09.009.
9
Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.与透析患者和健康儿童相比，SARS-CoV-2 mRNA BNT162b2 疫苗在儿科肾移植受者中的体液和细胞免疫反应。
Pediatr Nephrol. 2023 Jul;38(7):2199-2208. doi: 10.1007/s00467-022-05813-w. Epub 2022 Dec 2.
10
Chronic hemodialysis patients with COVID-19 cared for by the public health system have higher mortality than those treated in private facilities: analysis of the Brazilian dialysis registry.慢性血液透析 COVID-19 患者由公共卫生系统护理的死亡率高于在私人机构治疗的患者：巴西透析登记处的分析。
Int Urol Nephrol. 2023 Feb;55(2):449-458. doi: 10.1007/s11255-022-03289-z. Epub 2022 Aug 22.
意大利伦巴第大区一家大型血液透析中心的新冠疫情。
Kidney Int Rep. 2020 May 24;5(7):1095-1099. doi: 10.1016/j.ekir.2020.05.019. eCollection 2020 Jul.
4
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.肾功能对 COVID-19 患者入院的影响：对国际 HOPE COVID-19（COVID-19 健康结果预测评估）登记的分析。
J Nephrol. 2020 Aug;33(4):737-745. doi: 10.1007/s40620-020-00790-5. Epub 2020 Jun 29.
5
Microbiota and Allogeneic Hematopoietic-Cell Transplantation.
N Engl J Med. 2020 Jun 11;382(24):2378. doi: 10.1056/NEJMc2006694.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Renal impairment and outcomes in heart failure: systematic review and meta-analysis.肾功能损害与心力衰竭的预后：系统评价与荟萃分析。
J Am Coll Cardiol. 2006 May 16;47(10):1987-96. doi: 10.1016/j.jacc.2005.11.084. Epub 2006 Apr 24.